QT-interval monitoring is recommended by the American Heart Association (AHA) for several conditions: administration of medications that prolong the QT interval, overdose of medications that prolong the QT interval, electrolyte disturbances (K+, Mg+), and bradycardia. It is not known what proportion of patients meet these criteria and would benefit from QT interval monitoring.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here